AGPAT9 blocking peptide product blog
Tags: Blocking Peptide; AGPAT9; AGPAT9 blocking peptide;
The AGPAT9 gpat3 (Catalog #MBS9223039) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The AGPAT9 gpat3 product has the following accession number(s) (GI #150403919) (NCBI Accession #Q53EU6.2) (Uniprot Accession #Q53EU6). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
May transfer the acyl-group from acyl-coA to the sn-1 position of glycerol-3-phosphate, an essential step in glycerolipid biosynthesis. Also transfers the acyl-group from acyl-coA to the sn-2 position of 1-acyl-sn-glycerol-3-phosphate (lysophosphatidic acid, or LPA), forming 1,2-diacyl-sn-glycerol-3- phosphate (phosphatidic acid, or PA).
Cellular Location: Endoplasmic reticulum membrane; Multi- pass membrane protein. Tissue Location: Widely expressed. Expressed in liver, kidney, testis, brain, heart, skeletal muscle, thyroid, prostate, thymus and placenta. Also expressed lung and adipose tissue. Disease Models, Animal, Fatty Liver, Heart Diseases, Kidney Diseases, Liver Diseases, Weight Gain are some of the diseases may be linked to AGPAT9 Antibody (Center) Blocking Peptide. Blood, Brain, Connective Tissue, Intestine, Kidney, Liver, Ovary, Placenta, Testis, Vascular tissues are correlated with this protein. The following patways have been known to be associated with this gene.